Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Chemotherapy Followed by Peripheral Stem Cell Transplantation as First Line Therapy for Metastatic Triple-negative Breast Cancer

NCT02183805 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.

NCT NCT02183805
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02183805 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Chemotherapy Followed by Peripheral Stem Cell Transplantation as First Line Therapy for Metastatic Triple-negative Breast Cancer
Lead sponsor
Sun Yat-sen University
Phase
Phase 2
Overall status
Terminated
Start date
June 17, 2014
Completion date
December 15, 2020
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma breast stage iv